Authors: Lee, H Akita, RW Sliwkowski, MX Maihle, NJ

Citation: H. Lee et al., A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4, CANCER RES, 61(11), 2001, pp. 4467-4473

Authors: Kern, JA Akita, RW Sliwkowski, MX

Citation: Ja. Kern et al., Neuregulin receptor-mediated gene transfer by human epidermal growth factor receptor 2-targeted antibodies and neuregulin-1 (vol 6, pg 537, 1999), CANC GENE T, 7(2), 2000, pp. 166-166

Authors: Agus, DB Akita, RW Fox, WD Lofgren, JA Higgins, B Maiese, K Scher, HI Sliwkowski, MX

Citation: Db. Agus et al., A potential role for activated HER-2 in prostate cancer, SEMIN ONCOL, 27(6), 2000, pp. 76-83

Authors: Aguilar, Z Akita, RW Finn, RS Ramos, BL Pegram, MD Kabbinavar, FF Pietras, RJ Pisacane, P Sliwkowski, MX Slamon, DJ

Citation: Z. Aguilar et al., Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells, ONCOGENE, 18(44), 1999, pp. 6050-6062

Authors: Schaefer, G Akita, RW Sliwkowski, MX

Citation: G. Schaefer et al., A discrete three-amino acid segment (LVI) at the C-terminal end of kinase-impaired ErbB3 is required for transactivation of ErbB2, J BIOL CHEM, 274(2), 1999, pp. 859-866

Authors: Jones, JT Akita, RW Sliwkowski, MX

Citation: Jt. Jones et al., Binding specificities and affinities of egf domains for ErbB receptors, FEBS LETTER, 447(2-3), 1999, pp. 227-231